The Safety Profile of Biologic Therapy in Older IBD Patients - A Pilot Study

Purpose: Biologic therapy has become an important part of the treatment of patients with IBD. The safety profile of these medications has been established through clinical trials, case series from clinical practice, and large post-marketing follow up studies. However, relatively little is known about the safety profile of these medications in older IBD patients. Thus, we assessed the short-and long-term safety of infliximab (IFX) and adalimumab...